Of clinical relevance, the mechanistic insight gained from this study may guide the design of novel therapeutic approaches for the treatment of SLE which target CD137-CD137L signaling, and explore CD137 and CD137L as a prognostic biomarkers of SLE. The gene discussed is TNFSF9; the disease is systemic lupus erythematosus.